1-3 of 3
Keywords: IL-6/STAT3 signaling
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Retraction: Fingolimod inhibits proliferation and epithelial- mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signaling

Journal: Bioscience Reports
Biosci Rep (2020) 40 (7): BSR-20200221_RET.
DOI: https://doi.org/10.1042/BSR-20200221_RET
Published: 03 July 2020
... © 2020 The Author(s). 2020 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . epithelial-mesenchymal transition FTY720 IL-6/STAT3 signaling...
View article titled, Retraction: Fingolimod inhibits proliferation and epithelial- mesenchymal transition in sacral chordoma by inactivating <span class="search-highlight">IL</span>-<span class="search-highlight">6</span>&#x2F;<span class="search-highlight">STAT3</span> <span class="search-highlight">signaling</span>
Click here to open pdf in another window PDF for Retraction: Fingolimod inhibits proliferation and epithelial- mesenchymal transition in sacral chordoma by inactivating <span class="search-highlight">IL</span>-<span class="search-highlight">6</span>/<span class="search-highlight">STAT3</span> <span class="search-highlight">signaling</span>
Articles

Expression of Concern: Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signaling

Journal: Bioscience Reports
Biosci Rep (2020) 40 (6): BSR-20200221_EOC.
DOI: https://doi.org/10.1042/BSR-20200221_EOC
Published: 24 June 2020
...-6/STAT3 signaling The Editorial Office has been made aware of potential issues surrounding the scientific validity of this paper, hence has issued an expression of concern to notify readers whilst the Editorial Office investigates. ...
View article titled, Expression of Concern: Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating <span class="search-highlight">IL</span>-<span class="search-highlight">6</span>&#x2F;<span class="search-highlight">STAT3</span> <span class="search-highlight">signaling</span>
Click here to open pdf in another window PDF for Expression of Concern: Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating <span class="search-highlight">IL</span>-<span class="search-highlight">6</span>/<span class="search-highlight">STAT3</span> <span class="search-highlight">signaling</span>
Articles

Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling

Jiaqi Wang, Wenhao Hu, Xiaowen Du, Ying Sun, Shuai Han, Guanjun Tu
Journal: Bioscience Reports
Biosci Rep (2020) 40 (2): BSR20200221.
DOI: https://doi.org/10.1042/BSR20200221
Published: 18 February 2020
..., Minneapolis, MN, U.S.A.) was dissolved in sterile PBS (HyClone) at 100 μg/ml and administered to cells at 20 ng/ml as previously described [ 23 ]. epithelial-mesenchymal transition FTY720 IL-6/STAT3 signaling proliferation sacral chordoma Chordoma is the fourth most prevalent malignant...
View article titled, Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating <span class="search-highlight">IL</span>-<span class="search-highlight">6</span>&#x2F;<span class="search-highlight">STAT3</span> <span class="search-highlight">signalling</span>
Click here to open pdf in another window PDF for Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating <span class="search-highlight">IL</span>-<span class="search-highlight">6</span>/<span class="search-highlight">STAT3</span> <span class="search-highlight">signalling</span>